These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6485748)

  • 1. Antibodies against oligodendrocytes in serum and CSF in multiple sclerosis and other neurological diseases: 125I-protein A studies.
    Steck AJ; Link H
    Acta Neurol Scand; 1984 Aug; 70(2):81-9. PubMed ID: 6485748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioligodendrocyte antibodies in cerebrospinal fluid of multiple sclerosis and other neurologic diseases.
    Traugott U; Raine CS
    Neurology; 1981 Jun; 31(6):695-700. PubMed ID: 7017459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendrocyte-binding antibodies in multiple sclerosis: 125I-protein A studies.
    Steck AJ; Regli F
    Neurology; 1980 May; 30(5):540-2. PubMed ID: 7189260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
    Matà S; Lolli F; Söderström M; Pinto F; Link H
    Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases.
    Górny MK; Wróblewska Z; Pleasure D; Miller SL; Wajgt A; Koprowski H
    Acta Neurol Scand; 1983 Jun; 67(6):338-47. PubMed ID: 6193672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases.
    Suchanek G; Kristoferitsch W; Stanek G; Bernheimer H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):160-8. PubMed ID: 3577478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The study of anti-oligodendrocyte antibody in sera, and CSF of patients with multiple sclerosis].
    Hirayama M; Kawai K; Iida M
    Rinsho Shinkeigaku; 1990 Mar; 30(3):262-5. PubMed ID: 2364627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
    Rawes JA; Calabrese VP; Khan OA; DeVries GH
    Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-GFAP antibodies in the cerebrospinal fluid of patients with multiple sclerosis and other neurologic diseases].
    Górny M; Losy J; Wender M
    Neurol Neurochir Pol; 1990; 24(1-2):17-22. PubMed ID: 2132049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders.
    Reindl M; Khantane S; Ehling R; Schanda K; Lutterotti A; Brinkhoff C; Oertle T; Schwab ME; Deisenhammer F; Berger T; Bandtlow CE
    J Neuroimmunol; 2003 Dec; 145(1-2):139-47. PubMed ID: 14644040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference values for CSF-IgM, CSF-IgM/S-IgM ratio and IgM index, and its application to patients with multiple sclerosis and aseptic meningoencephalitis.
    Forsberg P; Henriksson A; Link H; Ohman S
    Scand J Clin Lab Invest; 1984 Feb; 44(1):7-12. PubMed ID: 6701452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes.
    Ma BI; Joseph BS; Walsh MJ; Potvin AR; Tourtellotte WW
    Ann Neurol; 1981 Apr; 9(4):371-7. PubMed ID: 6452854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescent staining of rat brain glial cells with multiple sclerosis serum.
    Singh VK; Mashal RD
    Can J Neurol Sci; 1981 May; 8(2):143-5. PubMed ID: 7028233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulins within the central nervous system in primary Sjögren's syndrome.
    Vrethem M; Ernerudh J; Lindström F; Skogh T
    J Neurol Sci; 1990 Dec; 100(1-2):186-92. PubMed ID: 1708408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte responsiveness to oligodendrocytes in multiple sclerosis.
    Traugott U; Scheinberg LC; Raine CS
    J Neuroimmunol; 1981 Mar; 1(1):41-51. PubMed ID: 7035492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
    Wajgt A; Górny M
    Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence of local synthesis of smooth-muscle antibodies in the central nervous system in isolated cases of multiple sclerosis and chronic lymphocytic meningoencephalitis.
    Nordal GJ; Vandvik B
    Scand J Immunol; 1977; 6(4):327-34. PubMed ID: 854708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.